Meng Jiao J - OmicsDI

Show results for

Unknown (669)
Proteomics (33)
Metabolomics (2)

Organisms

Homo sapiens (13)
Gazella dorcas (8)
Cervidae (8)
Diceros bicornis (8)
Rhinoceros unicornis (8)
Lepus sp. (8)
Aepyceros melampus (8)
Giraffa camelopardalis (8)
Ammotragus lervia (8)
Lacrimispora saccharolytica (8)
sludge granule bacterium 1 (8)
Cygnus (8)
Pusa sibirica (8)
Phoca vitulina (8)
Tragelaphus spekii (8)
Palaeoloxodon (8)
Elephas maximus (8)
Palaemon serratus (8)
Connochaetes gnou (8)
Mustela putorius (8)
Proteles cristata (8)
Escherichia coli (5)
Mycobacterium tuberculosis H37Rv_2009 (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Macaca fascicularis fascicularis (1)
Chlorocebus sabaeus (1)
Saccharomyces cerevisiae (1)
Mus (1)
Ovis aries (1)
Mus musculus (1)

Repository

iProX (25)
pride (8)
MetaboLights (2)

Tissue

Oocyte (3)
Embryo (3)
Lung (2)
Cell culture (2)
Seed (1)
Heart (1)
Blood (1)

Technology Type

Mass Spectrometry (8)
Shotgun proteomics (4)
Bottom-up proteomics (2)
Mass spectrometry (1)
Mass spectrometry assay (1)
Gel-based experiment (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2021 (10)
2022 (8)
2025 (5)
2024 (5)
2020 (3)
2026 (2)
2023 (2)

CHEBI ID

CHEBI:167251 (1)
CHEBI:183962 (1)
CHEBI:167296 (1)
CHEBI:85864 (1)
CHEBI:183810 (1)
CHEBI:167312 (1)
CHEBI:167264 (1)
CHEBI:156124 (1)
CHEBI:167253 (1)
CHEBI:166947 (1)
CHEBI:166944 (1)
CHEBI:166913 (1)
CHEBI:167241 (1)
CHEBI:85760 (1)
CHEBI:133629 (1)
CHEBI:167303 (1)
CHEBI:167299 (1)
CHEBI:167298 (1)
CHEBI:167265 (1)
CHEBI:166945 (1)
CHEBI:167254 (1)
CHEBI:167306 (1)
CHEBI:167276 (1)
CHEBI:167275 (1)
CHEBI:167272 (1)
CHEBI:167273 (1)
CHEBI:167261 (1)
CHEBI:167263 (1)
CHEBI:167259 (1)
CHEBI:167256 (1)

Metabolite Name

Sphingomyelin d38:1 (SM d38:1) (1)
Sphingomyelin d34:1 (SM d34:1) (1)
Sphingomyelin d42:2 (SM d42:2) (1)
Sphingomyelin d36:1 (SM d36:1) (1)
Sphingomyelin d42:1 (SM d42:1) (1)
Sphingomyelin d42:3 (SM d42:3) (1)
Sphingomyelin d38:2 (SM d38:2) (1)
Sphingomyelin d37:1 (SM d37:1) (1)
PG(18:1_18:2) (1)
PE(18:0_18:1) (1)
PE(20:0_20:4) (1)
PC(16:0_22:4) (1)
PGD2 ethanolamide (1)
Oxobutanedioic acid (1)
Estrone-3-glucuronide (1)
(9xi,10xi,12xi)-9,10-Dihydroxy-12-octadecenoic acid (1)
Acetovanillone (1)
2,6-Pyridinedicarboxylic acid (1)
4-Aminohippuric?acid (1)
L-Pyroglutamic?acid (1)
Kynurenic?acid (1)
Succinic?acid (1)
Beta-Hydroxypyruvic acid (1)
Phenylpyruvic?acid (1)
Gentisaldehyde (1)
4-Hydroxyphenylpyruvate (1)
Cirsiliol (1)
Galabiose (1)
LPE(20:4) (1)
LPC(20:4) (1)

Release Date

2025 (98)
2023 (98)
2024 (93)
2022 (92)
2020 (89)
2021 (74)
2019 (25)
2018 (18)
2015 (17)
2017 (15)
2016 (14)
2026 (13)
2014 (6)
2013 (4)
2012 (3)
2011 (3)
2009 (3)
2010 (2)
2007 (2)

Lab affiliation

Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 (2)
Jun Jim Zhangjunjimzhang@sjtu.edu.cnMinistry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University Schoole of Medicine (1)
Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine (1)
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China. (1)
Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China (1)
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China (1)

Previous page
1 / 71
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 71
Next page

Sort by:

Relevance

Page size

Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy

Numerous studies found intestinal microbiota alterations which are thought to affect the development of various diseases through the production of gut-derived metabolites. However, the specific metabolites and their pathophysiological contribution to cardiac hypertrophy or heart failure progression ...

2021-12-08 | MTBLS3174 | MetaboLights

Atomically Dispersed Iron Active Sites Promoting Reversible Redox Kinetics and Suppressing Shuttle Effect in Aluminum-Sulfur Batteries.

Not available

S-EPMC9392677 | biostudies-literature

Air-Stable Binary Hydrated Eutectic Electrolytes with Unique Solvation Structure for Rechargeable Aluminum-Ion Batteries.

Not available

S-EPMC10387020 | biostudies-literature

iotin-streptavidin affinity purification mass spectrometry of proteins in human 293T cell using bioinylated Orf9b

COVID-19, caused by the new RNA virus strain SARS-CoV-2, is a serious acute respiratory disease. One of the prominent feature of SARS-COV-2 in terms of immune responses is that it triggers very low level responses of IFN-I in cells or COVID-19 patients. Previously SARS-CoV Orf9b were reported to be ...

ORGANISM(S): Homo sapiens (Human)

2021-09-09 | PXD019803 | Pride